210 related articles for article (PubMed ID: 36350827)
1. ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia.
Kodgule R; Goldman JW; Monovich AC; Saari T; Aguilar AR; Hall CN; Rajesh N; Gupta J; Chu SA; Ye L; Gurumurthy A; Iyer A; Brown NA; Chiang MY; Cieslik MP; Ryan RJH
Blood Cancer Discov; 2023 Jan; 4(1):34-53. PubMed ID: 36350827
[TBL] [Abstract][Full Text] [Related]
2. ETS Fight Club on Microsatellite Enhancers.
Mercher T
Blood Cancer Discov; 2023 Jan; 4(1):2-4. PubMed ID: 36538046
[TBL] [Abstract][Full Text] [Related]
3. RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children.
Chen D; Camponeschi A; Nordlund J; Marincevic-Zuniga Y; Abrahamsson J; Lönnerholm G; Fogelstrand L; Mårtensson IL
Cancer Med; 2021 Jun; 10(12):3997-4003. PubMed ID: 33987955
[TBL] [Abstract][Full Text] [Related]
4. Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
Ghazavi F; De Moerloose B; Van Loocke W; Wallaert A; Helsmoortel HH; Ferster A; Bakkus M; Plat G; Delabesse E; Uyttebroeck A; Van Nieuwerburgh F; Deforce D; Van Roy N; Speleman F; Benoit Y; Lammens T; Van Vlierberghe P
Oncotarget; 2016 Nov; 7(45):73769-73780. PubMed ID: 27650541
[TBL] [Abstract][Full Text] [Related]
5. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
[TBL] [Abstract][Full Text] [Related]
6. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M
Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299
[TBL] [Abstract][Full Text] [Related]
7. Infection Exposure Promotes
Rodríguez-Hernández G; Hauer J; Martín-Lorenzo A; Schäfer D; Bartenhagen C; García-Ramírez I; Auer F; González-Herrero I; Ruiz-Roca L; Gombert M; Okpanyi V; Fischer U; Chen C; Dugas M; Bhatia S; Linka RM; Garcia-Suquia M; Rascón-Trincado MV; Garcia-Sanchez A; Blanco O; García-Cenador MB; García-Criado FJ; Cobaleda C; Alonso-López D; De Las Rivas J; Müschen M; Vicente-Dueñas C; Sánchez-García I; Borkhardt A
Cancer Res; 2017 Aug; 77(16):4365-4377. PubMed ID: 28630052
[No Abstract] [Full Text] [Related]
8. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
Jakobczyk H; Debaize L; Soubise B; Avner S; Rouger-Gaudichon J; Commet S; Jiang Y; Sérandour AA; Rio AG; Carroll JS; Wichmann C; Lie-A-Ling M; Lacaud G; Corcos L; Salbert G; Galibert MD; Gandemer V; Troadec MB
J Hematol Oncol; 2021 Mar; 14(1):47. PubMed ID: 33743795
[TBL] [Abstract][Full Text] [Related]
9. Investigation of lncRNA-mRNA co-expression network in ETV6-RUNX1-positive pediatric B-cell acute lymphoblastic leukemia.
Yu W; Wang W; Yu X
PLoS One; 2021; 16(6):e0253012. PubMed ID: 34101758
[TBL] [Abstract][Full Text] [Related]
10. RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL.
Pais AP; Amare Kadam PS; Raje GC; Banavali S; Parikh P; Kurkure P; Arora B; Gujral S; Kumar SA; Badrinath Y
Pediatr Hematol Oncol; 2008 Sep; 25(6):582-97. PubMed ID: 18728978
[TBL] [Abstract][Full Text] [Related]
11. RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia.
Sharma G; Tran TM; Bansal I; Beg MS; Bhardwaj R; Bassi J; Tan Y; Jaiswal AK; Tso C; Jain A; Singh J; Chattopadhyay P; Singh A; Chopra A; Bakhshi S; Casero D; Rao DS; Palanichamy JK
J Exp Clin Cancer Res; 2023 Sep; 42(1):231. PubMed ID: 37670323
[TBL] [Abstract][Full Text] [Related]
12. Somatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5(+/-) leukemia.
van der Weyden L; Giotopoulos G; Wong K; Rust AG; Robles-Espinoza CD; Osaki H; Huntly BJ; Adams DJ
BMC Cancer; 2015 Aug; 15():585. PubMed ID: 26269126
[TBL] [Abstract][Full Text] [Related]
13. ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.
Zaliova M; Kotrova M; Bresolin S; Stuchly J; Stary J; Hrusak O; Te Kronnie G; Trka J; Zuna J; Vaskova M
Genes Chromosomes Cancer; 2017 Aug; 56(8):608-616. PubMed ID: 28395118
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of RUNX1 and ETV6 gene copy number on pediatric B-cell precursor acute lymphoblastic leukemia with or without hyperdiploidy.
Kutlay NY; Pekpak E; Altıner S; Ileri T; Vicdan AN; Dinçaslan H; Ince EU; Tukun FA
Int J Hematol; 2016 Sep; 104(3):368-77. PubMed ID: 27393278
[TBL] [Abstract][Full Text] [Related]
15. The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21).
Kaczmarska A; Derebas J; Pinkosz M; Niedźwiecki M; Lejman M
Cells; 2023 Jan; 12(3):. PubMed ID: 36766699
[TBL] [Abstract][Full Text] [Related]
16. Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia.
Harder L; Eschenburg G; Zech A; Kriebitzsch N; Otto B; Streichert T; Behlich AS; Dierck K; Klingler B; Hansen A; Stanulla M; Zimmermann M; Kremmer E; Stocking C; Horstmann MA
J Exp Med; 2013 Oct; 210(11):2289-304. PubMed ID: 24081948
[TBL] [Abstract][Full Text] [Related]
17. E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.
Pi WC; Wang J; Shimada M; Lin JW; Geng H; Lee YL; Lu R; Li D; Wang GG; Roeder RG; Chen WY
Blood; 2020 Jul; 136(1):11-23. PubMed ID: 32276273
[TBL] [Abstract][Full Text] [Related]
18. High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia.
Vendramini E; Giordan M; Giarin E; Michielotto B; Fazio G; Cazzaniga G; Biondi A; Silvestri D; Valsecchi MG; Muckenthaler MU; Kulozik AE; Gattei V; Izraeli S; Basso G; Te Kronnie G
Oncotarget; 2017 Jun; 8(26):42398-42413. PubMed ID: 28415578
[TBL] [Abstract][Full Text] [Related]
19. A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia.
Yang YL; Yen CT; Pai CH; Chen HY; Yu SL; Lin CY; Hu CY; Jou ST; Lin DT; Lin SR; Lin SW
PLoS One; 2015; 10(11):e0142863. PubMed ID: 26580398
[TBL] [Abstract][Full Text] [Related]
20. RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia.
Papaemmanuil E; Rapado I; Li Y; Potter NE; Wedge DC; Tubio J; Alexandrov LB; Van Loo P; Cooke SL; Marshall J; Martincorena I; Hinton J; Gundem G; van Delft FW; Nik-Zainal S; Jones DR; Ramakrishna M; Titley I; Stebbings L; Leroy C; Menzies A; Gamble J; Robinson B; Mudie L; Raine K; O'Meara S; Teague JW; Butler AP; Cazzaniga G; Biondi A; Zuna J; Kempski H; Muschen M; Ford AM; Stratton MR; Greaves M; Campbell PJ
Nat Genet; 2014 Feb; 46(2):116-25. PubMed ID: 24413735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
